NCT06511323 Evaluation of Brain Metastases Treated With Stereotactic Radiotherapy Using Dynamic [18F]FDG PET Status NOT_YET_RECRUITING Phase NA
NCT06501391 Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Stable Brain Metastasis Status RECRUITING Phase PHASE2
NCT06476093 SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung Cancer Status RECRUITING Phase NA
NCT06471465 Corticodependent or Corticoresistant Brain Radionecrosis After Radiotherapy for Brain Metastases Status RECRUITING Phase PHASE3
NCT06466720 Measuring and Mapping Cognitive Decline After Brain Radiosurgery Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06457906 SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in SCLC Status RECRUITING Phase PHASE3
NCT06410040 A Retrospective Study of the Efficacy and Safety of Lolatinib in ALK+ NSCLC Patients With Brain or Meningeal Metastasis Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06405256 Magnetic Resonance Imaging-guided Adaptive Radiotherapy for Large Brain Metastases Status RECRUITING Phase N/A
NCT06322342 Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent Status COMPLETED Phase PHASE2
NCT06318065 Surgical Resection Outcomes in Patients With Brain Metastasis Status RECRUITING Phase N/A
NCT06315010 REPotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain mEtastasis Status RECRUITING Phase PHASE2
NCT06282874 Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06243003 WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases Status RECRUITING Phase PHASE1/PHASE2
NCT06238882 Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer. Status RECRUITING Phase NA
NCT06209567 A Study of 68Ga-PSMA-11 PET Scans in People With Brain Tumors Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT06194929 Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma Status RECRUITING Phase PHASE1/PHASE2
NCT06132945 A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06101069 Development of MRF for Characterization of Brain Tumors After Radiotherapy Status RECRUITING Phase NA